ArticleAnnals of medicine and surgery (2012)2024

Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for muscle-invasive bladder cancer: case series.

Ze Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.